Israeli medical machine startup Hospitech Respiration provided the AnapnoGuard system to hospitals within the nation, on a free loan-foundation in March. The answer was first launched by Rambam Medical Centre, the biggest educational centre in northern Israel.
Amid a brand new spike within the variety of ventilated sufferers, AnapnoGuard has now additionally been adopted by the Sheba Medical Centre, Yitzhak Shamir Medical Centre and Wolfson Medical Centre.
WHY IT MATTERS
AnapnoGuard consists of an automated management unit (AG100s) and a proprietary multi lumen endotracheal tube (AG ETT) which prevents ventilator-associated problems, together with ventilator related pneumonia (VAP) and damage to the trachea.
The system works alongside and is complementary to the ventilator. It gives automated airway cuff strain administration and automatic evacuation of the subglottic secretions, which scale back the chance of pulmonary infections and the incidence of tracheal damage.
THE LARGER CONTEXT
Since easing its lockdown in April, Israel has confronted a resurgence of COVID-19. New circumstances had fallen to round 20 a day in mid-Might, however elevated to greater than 1,000 a day in July, prompting the nation to return to a partial lockdown.
The figures have continued to rise with the most recent WHO statistics recording 2,190 new circumstances on three September.
In a current interview, head of Israel’s Directorate of Defence Analysis and Growth Brig. Gen. (Ret.) Dr. Daniel Gold discusses how the nation is utilizing its navy defence experience to battle the virus via medical units, diagnostics and information intelligence instruments.
ON THE RECORD
Prof. Gil Bolotin, director of the division of cardiac surgical procedure on the Rambam Medical Centre in Haifa, Israel stated: “My division has been utilizing the AnapnoGuard system when treating high-risk ventilated sufferers. Throughout this time, now we have seen a major discount within the variety of sufferers who developed lung and pulmonary infections following intubation.”
Yoav Venkert, CEO of Hospitech Respiration, stated: “The outbreak of COVID-19 has highlighted the necessity of healthcare methods to search out new and progressive options to medical challenges they’re dealing with.”
Tzipi Yakoby, VP scientific of Hospitech Respiration, stated: “Over the previous month, now we have been working with a number of the finest medical groups in Israel to put in our AnapnoGuard methods in Intensive Care items. The distinctive options of our system don’t solely allow us to considerably scale back air flow problems in intubated sufferers, but in addition minimise the publicity of scientific groups to contamination.”